Citeline is the industry’s most comprehensive, reliable and current global R&D intelligence suite of solutions. Built by experts, made for experts, Citeline solutions transform data into knowledge. And now our new, next generation platform delivers unparalleled access to Citeline’s robust clinical trial intelligence. With greater ease, speed and efficiency than ever before, Citeline’s next generation platform will help you gain critical insights into the global clinical trial landscape and realize greater cost-savings as you develop on your clinical trial programs.
What Citeline does:
Citeline organizes vast quantities of data with human intelligence to greatly reduce research time, clinical trial costs and optimize trial outcomes. It features an unmatched collection of critical information on global clinical trials, investigators and sites, and drug development pipelines all with direct expert analyst support. Stay updated on what your competitors are doing with full public domain coverage of over 40,000 sources, continuous updating and full record reviews, advanced indexing and proprietary content.
Gain key insights that can be turned into actionable results with unparalleled access to 265,000+ clinical trials, 400,000 investigators, 68,000+ drugs, 117,000+ sites, 235+ diseases in 8 major therapeutic areas across 166 countries. And our 250+ therapeutic area experts and analysts are dedicated to provide the support needed so that you’re getting the most appropriate data to meet your requirements.
Our Ask-the-Analyst service is your direct hotline to the team of experts who cover all aspects of the Pharmaceutical market including R&D, clinical trials, market access, financing and licensing.
In this data-packed visual resource, you will find illuminating information about upcoming patent expirations at the Top 10 pharma companies. Find out which companies have the most patents due to expire soon and over the next three years, which therapy areas will be most affected the sales potential of the top 10 drugs with a US Patent expiry and more.
The 23rd Annual International Partnering Conference, Bio Europe 2017, November 6 – 8, in Berlin, Germany is fast approaching. Via one-on-one partnering meetings, attendees over the world from all facets of biotech will meet at Europe’s largest life science partnering conference to identify, engage with, and enter into strategic relationships to drive their business forward.
Royalty payments are an essential component of most pharmaceutical deals. Along with upfront payments and milestones, companies are rewarded for surpassing certain developmental hurdles.
Medtrack: 製薬企業などヘルスケア企業情報のデータベース, Trialtrove: 医療用医薬品の臨床試験情報デ...
Experts from Informa’s Medtrack, Trialtrove and Strategic Transactions teams presented a panel discussion at the recent T3 Conference in Orlando, Florida.
Partnering came into use twenty-odd years ago when pharmaceutical companies began working with biotech and increasingly sought external discovery and development opportunities.
An analysis of deals in the pharmaceutical sector was assembled using Medtrack’s Deals Analyzer.